TABLE 4.

Side Effects Expectations and Management: Baseline Results Among Women in Control and Intervention Groups, Among Women Who Received a Method

 Did the Provider Tell You About Side Effects You Might Experience With Your Chosen Method? Did the Provider Help You Make a Plan to Manage Side Effects? If You Experience Side Effects, Will You Discontinue Your Method Immediately?
 Control, No. (%)Intervention, No. (%) Control, No. (%)Intervention, No. (%) Control, No. (%)Intervention, No. (%)
Yes180 (38.1)412 (72.5) 194 (41.0)441 (77.6) 52 (11.0)40 (7.0)
No293 (62.0)156 (27.5) 279 (59.0)127 (22.4) 421 (89.0)528 (93.0)
ORa (95% CI)6.62b (3.24, 13.53) 8.89b (3.77, 20.96) 0.67 (0.40, 1.13)
aORc (95% CI)5.98b (2.97, 12.03) 8.79b (3.68, 21.01) 0.79 (0.45, 1.40)
ICCd0.45 0.55 0.09
σu2e1.56 2.59 0.26
Observationsf1,038 1,038 1,024
  • Abbreviations: aOR, adjusted odds ratio; CI, confidence interval; ICC, intraclass correlation; OR, odds ratio.

  • a Estimated from multilevel mixed effects model with ordinal or binary outcomes. Unadjusted odds ratios estimated from bivariate models.

  • b Significant at P<.01.

  • c Estimated from models that include demographic variables (age, marital status, education), a categorical variable for number of living children (defined as none, 1–2, 3–4, or 5 or more), and variables for method chosen at provider visit and type of facility (public or private).

  • d Estimated from unadjusted model with random intercepts for health facility but without fixed effects predictors.

  • e Estimated variance for the random effects at the health facility level; estimate has not been exponentiated.

  • f Number of observations in the adjusted model.